Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data
Endocrinology and Metabolism · 2025
DOI: 10.3803/enm.2024.2252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Kyoung Jin Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Osteoporosis, Postmenopausal, Practice Patterns, Physicians'. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health and Welfare, Korea Health Industry Development Institute, Ministry of Science and ICT.
Abstract (Originalsprache)
Background
Osteoporosis is a global health concern. Despite emerging treatment options for this condition, limited data are available on hospital practices in South Korea. This study addresses the need for a hospital network database that reflects changes in routine clinical practice for osteoporosis in a timely manner.
Methods
We analyzed prescription patterns for anti-osteoporosis medications (AOMs) in postmenopausal women aged ≥50 years diagnosed with osteoporosis between 2012 and 2021 using data from Osteoporosis Analysis and Surveillance Initiative using Standardized data (OASIS) (four tertiary hospitals in South Korea) and a nationwide database from the Health Insurance Review and Assessment (HIRA) Service. AOMs were categorized into antiresorptive and anabolic agents, with a focus on secular changes in the use of oral bisphosphonates, denosumab, selective estrogen receptor modulators (SERMs), and anabolic agents.
Results
In the OASIS cohort, oral bisphosphonates were the most prescribed first-line AOM (49.0%), followed by denosumab (15.7%) and SERMs (18.0%). Denosumab use increased from 2% in 2016 to 40% in 2020, while oral bisphosphonate use declined from 69% in 2012 to 22% in 2021. The use of anabolic agents, including romosozumab and teriparatide, doubled to 6% after 2019. In the HIRA cohort, parenteral bisphosphonates were most common (54.3%), with significant denosumab use (17.3%).
Conclusion
Pronounced shifts in AOM prescription patterns were observed in South Korea, marked by a notable increase in denosumab prescriptions and a decline in bisphosphonate use. These trends highlight the impact of policy changes and clinical guidelines on osteoporosis treatment and may inform future management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
- Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
- Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea.
- Big Data Research Center, Asan Institute of Life Science, Asan Medical Center, Seoul, Korea.
- Biomedical Research Institute, Inha University Hospital, Incheon, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Förderung
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
- Ministry of Science and ICT
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center
- NCIRD CDC HHS
Zitieren
APA
Kim, K. J., Boo, D., Choi, J., Yoon, H., Jung, C. Y., Ahn, S. H., Hong, N., Kim, B. J., Oh, J. S., & You, S. C. (2025). Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2024.2252
Vancouver
Kim KJ, Boo D, Choi J, Yoon H, Jung CY, Ahn SH, et al. Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2024.2252
BibTeX
@article{Kim2025,
author = {Kim, Kyoung Jin and Boo, Dachung and Choi, Jimi and Yoon, Hyemin and Jung, Chai Young and Ahn, Seong Hee and Hong, Namki and Kim, Beom-Jun and Oh, Ji Seon and You, Seng Chan},
title = {Comprehensive Evaluation of Treatment Patterns in Postmenopausal Patients with Osteoporosis without Fractures: Insights from Tertiary Care Institutions and Nationwide OMOP-CDM Data},
journal = {Endocrinology and Metabolism},
year = {2025},
doi = {10.3803/enm.2024.2252}
}
EUVIMED